Evidence map›Paper›PMID 37468746›Full record

ArticleScientific reports2023

Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro.

Adventina Padmyastuti, Marina Garcia Sarmiento, Maria Dib, Jens Ehrhardt, Janosch Schoon, Maryna Somova, Martin Burchardt, Cindy Roennau, Pedro Caetano Pinto

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Microphysiological systems as models for immunologically 'cold' tumors.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adventina PadmyastutiDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Marina Garcia SarmientoDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Maria DibDepartment of Ear, Nose and Throat Surgery, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Jens EhrhardtDepartment of Obstetrics and Gynecology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Janosch SchoonCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Fleichmannstraße 8, 17475, Greifswald, Germany.
Maryna SomovaDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Martin BurchardtDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Cindy RoennauDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany.
Pedro Caetano PintoDepartment of Urology, University Medicine Greifswald, Fleischmannstraße 8, 17475, Greifswald, Germany. pintop@uni-greifswald.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of prostate cancer in vitro relies on established cell lines that lack important physiological characteristics, such as proper polarization and expression of relevant biomarkers. Microphysiological systems (MPS) can replicate cancer microenvironments and lead to cellular phenotypic changes that better represent organ physiology in vitro. In this study, we developed an MPS model comprising conventional prostate cancer cells to evaluate their activity under dynamic culture conditions. Androgen-sensitive (LNCaP) and androgen-insensitive (PC3) cells were grown in conventional and 3D cultures, both static and dynamic. Cell morphology, the secretion of prostate-specific antigen, and the expression of key prostate markers and microRNAs were analyzed. LNCaP formed spheroids in 3D and MPS cultures, with morphological changes supported by the upregulation of cytokeratins and adhesion proteins. LNCaP also maintained a constant prostate-specific antigen secretion in MPS. PC3 cells did not develop complex structures in 3D and MPS cultures. PSA expression at the gene level was downregulated in LNCaP-MPS and considerably upregulated in PC3-MPS. MicroRNA expression was altered by the 3D static and dynamic culture, both intra- and extracellularly. MicroRNAs associated with prostate cancer progression were mostly upregulated in LNCaP-MPS. Overall dynamic cell culture substantially altered the morphology and expression of LNCaP cells, arguably augmenting their prostate cancer phenotype. This novel approach demonstrates that microRNA expression in prostate cancer cells is sensitive to external stimuli and that MPS can effectively promote important physiological changes in conventional prostate cancer models.

Indexed as

MicroRNAsProstatic NeoplasmsAndrogensCell Line, TumorHumansMaleMicrofluidicsProstateProstate-Specific AntigenTumor MicroenvironmentAndrogensMicroRNAsProstate-Specific Antigen

Identifiers

PMID37468746
PMCPMC10356943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.